Eyetech Pins Its Hopes (And Shares) On New Drug

Article Abstract:

Eyetech Pharmaceuticals is expected to receive approval for its macular degeration treatment Macugen, and while the company is generally looked at favorably, retina specialists are less enthusiastic about the medication itself.

Securities issued, listed, Alliances, partnerships, Licensing/Sales Agreements, Evaluation, Conferences, meetings and seminars, Securities, Pfizer Inc., Licensing agreements, Company licensing agreement, Cooperative agreement for product marketing, Gilead Sciences Inc., GILD, PFE, Company securities, Visudyne (Medication), Macular degeneration, Marketing agreements, Optometry, Eyetech Pharmaceuticals Inc., Macugen (Medication)

---

Drug Maker Acknowledges Some Negative Test Results

Article Abstract:

Forest Laboratories Inc. releases the results of clinical trials of two of its antidepressant medications. The prescribing of Celexa for depressed children and adolescents is put into question.

Pharmaceutical Preparation Manufacturing, Antidepressant Preparations, Marketing, Complications and side effects, Clinical trials, Access control, Dosage and administration, Records and correspondence, Company marketing practices, Antidepressants, Forest Laboratories Inc., FRX, Depression in children, Childhood depression, Celexa (Medication), Lexapro (Medication)

---

Medical Editors Likely To Call for Registration Of Drug Tests at Outset

Article Abstract:

A group of medical journal editors will push Congress to enact legislation that will force the pharmaceutical industry to publicly disclose the results of drug trials.

Legal issues & crime, Government regulation (cont), Research and Development in the Physical, Engineering, and Life Sciences, Government domestic functions, Government regulation, Research and Testing Services, Periodical Publishers, Public affairs, Medical Research, Epilepsy & Muscle Disease R&D, Periodicals, Legal/Government Regulation, Administration of Public Health Programs, Ethics, Health Research Programs, Medical Periodicals, Laws, regulations and rules, Reports, Political aspects, Ethical aspects, Health policy, Medicine, Experimental, Medical journals

Similar abstracts:

• Abstracts: Shell Turns a Stock Page But Has Chapters to Go. Shell Warns Of New Cuts In Reserves Of Oil and Gas. Shell Weighs Modifying Dual Setup
• Abstracts: Accused of Harassment, Fox Star Sues and Is Sued. Federal Effort To Head Off TV Piracy Is Challenged
• Abstracts: For a British Novelist, a Fictional Plot Jarringly Leads to a Real-Life Problem. A Quiet Revolt Puts Costly Journals on Web
• Abstracts: The Oil Market Refuses to Heed Positive News. A Tanker Shortage Contributes to Rising Oil Costs

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.